tenosynovial giant cell tumor
Showing 1 - 14 of 14
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath Trial (Pimicotinib(ABSK021),
Not yet recruiting
- Tenosynovial Giant Cell Tumor
- +2 more
- Pimicotinib(ABSK021)
- Placebo
- (no location specified)
Apr 5, 2023
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath Trial in Worldwide
Recruiting
- Tenosynovial Giant Cell Tumor
- +4 more
- vimseltinib
- Placebo
-
Duarte, California
- +34 more
Jan 17, 2023
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
- Pigmented Villonodular Synovitis
- AMB-05X
-
Columbus, Ohio
- +5 more
Oct 5, 2022
Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, TGCT Trial in Germany, Poland, Ukraine (AMB-05X)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
- +3 more
- AMB-05X
-
Berlin, Germany
- +4 more
Oct 5, 2022
Hepatotoxicity, Tenosynovial Giant Cell Tumor Trial in United States (TURALIO™)
Recruiting
- Hepatotoxicity
- Tenosynovial Giant Cell Tumor
-
Santa Monica, California
- +4 more
Jun 6, 2022
Tenosynovial Giant Cell Tumor Trial in Worldwide (Pexidartinib)
Active, not recruiting
- Tenosynovial Giant Cell Tumor
-
Scottsdale, Arizona
- +15 more
Apr 29, 2022
Pigmented Villonodular Synovitis, TGCT, Tenosynovial Giant Cell Tumor Trial (AMB-05X)
Not yet recruiting
- Pigmented Villonodular Synovitis
- +2 more
- AMB-05X
- (no location specified)
Apr 22, 2022
Pigmented Villonodular Synovitis, Diffuse-type Giant Cell Tumor, Tenosynovial Giant Cell Tumor Trial in United States
Active, not recruiting
- Pigmented Villonodular Synovitis
- +2 more
-
Santa Monica, California
- +6 more
Jan 31, 2022
Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor Trial in Worldwide (FPA008)
Completed
- Pigmented Villonodular Synovitis
- Tenosynovial Giant Cell Tumor
- FPA008
-
Los Angeles, California
- +11 more
Aug 4, 2021
Solid Tumor, Tumors of Any Histology With Activating Trk (NTRK) Point or NTRK Fusion Mutations, Tenosynovial Giant Cell Tumor
Terminated
- Solid Tumor
- +2 more
- PLX7486 TsOH
-
Los Angeles, California
- +3 more
Aug 1, 2018